<DOC>
	<DOC>NCT01089270</DOC>
	<brief_summary>Parkinson Disease is one of the most common neurodegenerative illnesses. First degree relatives of Parkinson patient are in high risk for developing the disease. We will try to detect early changes in brain metabolism before the appearance of Parkinson symptoms. Participants: first degree relatives of diagnosed Parkinson patients that carry a gene mutation in either LRRK2 or GBA genes. The examination results will be given to the participants by a doctor from the neurology department.</brief_summary>
	<brief_title>Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>healthy first degree relatives of diagnosed Parkinson patients patients unable to understand and sign an informed consent minors people with psychiatric disorders or a history of major head trauma</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Parkinson</keyword>
	<keyword>fdg pet-ct</keyword>
	<keyword>i123 dat scan</keyword>
	<keyword>first degree relatives of diagnosed Parkinson patients</keyword>
	<keyword>with no clinical evidence of movement disorders</keyword>
</DOC>